Constellation Brands/$STZ

1D1W1MYTD1Y5YMAX

About Constellation Brands

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Ticker
$STZ
Primary listing
NYSE
Employees
9,400

STZ Metrics

BasicAdvanced
$20B
11.36
$10.48
0.40
$4.10
3.46%

What the Analysts think about STZ

Analyst ratings (Buy, Hold, Sell) for Constellation Brands stock.
Analyst projections of the future price of Constellation Brands stock.

Bulls say / Bears say

Constellation exceeded expectations in Q1 FY2027, reporting comparable EPS of $3.43 versus the $3.20 analyst consensus, while affirming fiscal 2027 comparable EPS guidance of $11.20–$11.90. (investing.com) (Reuters)
The company continues to possess a strong premium-beer franchise: Modelo Especial remained the top U.S. beer brand by dollar sales, while Constellation’s beer business ranked first in dollar-share gains and Pacifico, Victoria, and Modelo Chelada brands posted notable growth. (ir.cbrands.com) (Constellation Brands)
Cash generation supports shareholder returns and investment: Q1 operating cash flow rose 4% to $662 million, free cash flow increased 9% to $485 million, and management maintained a fiscal 2027 free-cash-flow target of $1.6–$1.7 billion while repurchasing $324 million of shares year to date. (ir.cbrands.com) (Constellation Brands)
Core beer momentum is softening: Q1 FY2027 beer depletions fell 0.3%, with Modelo Especial down approximately 2% and Corona Extra down more than 5%. (ir.cbrands.com) (Constellation Brands)
Near-term growth expectations are subdued: management guided fiscal 2027 organic net sales growth of negative 1% to 1%, beer operating margins of 37%–38%, and withdrew its fiscal 2028 outlook because of limited visibility. (investing.com) (Reuters)
Wine and spirits remain a drag despite organic improvement: reported segment sales fell 47% year over year and the segment still posted a $1.1 million operating loss in Q1 FY2027, increasing reliance on the beer franchise. (ir.cbrands.com) (Constellation Brands)
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2026.

STZ Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

STZ Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.